111 related articles for article (PubMed ID: 11205844)
21. Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report.
Takatsuka H; Wakae T; Mori A; Okada M; Fujimori Y; Takemoto Y; Okamoto T; Sugihara A; Terada N; Kanamaru A; Kakishita E
Hematology; 2002 Jun; 7(3):169-72. PubMed ID: 12243980
[TBL] [Abstract][Full Text] [Related]
22. Recombinant tissue plasminogen activator (rTPA) for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient.
Feldman L; Gabai E; Milovic V; Jaimovich G
Bone Marrow Transplant; 1995 Nov; 16(5):727. PubMed ID: 8547875
[No Abstract] [Full Text] [Related]
23. [Endovascular therapy of superior vena cava syndrome: clinical case].
Boza C; Mertens R; Valdés F; Kramer A; Mariné L; Vergara J
Rev Med Chil; 2001 Apr; 129(4):421-6. PubMed ID: 11413995
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
25. Superior vena cava obstruction: diagnosis, management and outcome.
Adegboye VO; Ogunseyinde AO; Obajimi MO; Brimmo AI; Adebo OA
East Afr Med J; 2008 Mar; 85(3):129-36. PubMed ID: 18663886
[TBL] [Abstract][Full Text] [Related]
26. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
27. Etiology and outcome of superior vena cava (SVC) obstruction in adults.
Reechaipichitkul W; Thongpaen S
Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):453-7. PubMed ID: 15691155
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment of Budd-Chiari syndrome associated with superior vena cava obstruction; report of a case].
Sasahashi N; Yamanaka K; Nomoto S; Otani S; Hirose K; Kondo T; Morishima M; Sekine Y
Kyobu Geka; 2003 Jul; 56(7):573-6. PubMed ID: 12854466
[TBL] [Abstract][Full Text] [Related]
29. [Superior vena cava syndrome successfully controlled by metallic stent insertion].
Sakaguchi Y; Kono T; Terada Y; Noda H
Kyobu Geka; 2009 Jun; 62(6):460-3. PubMed ID: 19522205
[TBL] [Abstract][Full Text] [Related]
30. [Superior vena cava syndrome: Catheter association as a rare cause].
Hueber AJ; Leipe J; Schmid A; Kalden JR; Schulze-Koops H; Rech J
Dtsch Med Wochenschr; 2006 Dec; 131(49):2774-6. PubMed ID: 17136657
[TBL] [Abstract][Full Text] [Related]
31. Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
Fasano R; Kent P; Valentino L
J Pediatr Hematol Oncol; 2005 Dec; 27(12):692-5. PubMed ID: 16344681
[TBL] [Abstract][Full Text] [Related]
32. Endovascular treatment for superior vena cava occlusion or obstruction in a pediatric and young adult population: a 22-year experience.
Tzifa A; Marshall AC; McElhinney DB; Lock JE; Geggel RL
J Am Coll Cardiol; 2007 Mar; 49(9):1003-9. PubMed ID: 17336725
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and therapeutic challenges in a critically ill patient in ICU with superior vena cava syndrome--case report.
Mishra PA; Kausalya R; Jain R
Middle East J Anaesthesiol; 2011 Feb; 21(1):105-10. PubMed ID: 21991741
[TBL] [Abstract][Full Text] [Related]
34. Hepatic Veno-Occlusive Disease: A Role for Tissue Plasminogen Activator?
Partyka J; Kim J; Tate C
Cancer Control; 1994 May; 1(3):248-251. PubMed ID: 10886975
[TBL] [Abstract][Full Text] [Related]
35. Chylothorax as a complication of central venous catheter-induced superior vena cava thrombosis.
Schiller G
Bone Marrow Transplant; 1992 Apr; 9(4):302. PubMed ID: 1600417
[No Abstract] [Full Text] [Related]
36. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Hágglund H; Ringdén O; Ericzon BG; Duraj F; Ljungman P; Lönnqvist B; Winiarski J; Tydén G
Transplantation; 1996 Oct; 62(8):1076-80. PubMed ID: 8900305
[TBL] [Abstract][Full Text] [Related]
37. Central venous catheter thrombosis as a cause of SVC obstruction and cardiac tamponade in a patient with Diamond-Blackfan anemia and iron overload.
Norris ML; Klaassen R
Pediatr Blood Cancer; 2006 Jan; 46(1):112-4. PubMed ID: 15768384
[TBL] [Abstract][Full Text] [Related]
38. [Inferior vena cava obstruction syndrome caused by urinary retention].
Arruti A; Plazaola I; Mata J; Amato E
Arch Esp Urol; 1997; 50(1):61-2. PubMed ID: 9182491
[TBL] [Abstract][Full Text] [Related]
39. Surgical reconstruction of the superior vena cava system: indications and results.
Picquet J; Blin V; Dussaussoy C; Jousset Y; Papon X; Enon B
Surgery; 2009 Jan; 145(1):93-9. PubMed ID: 19081480
[TBL] [Abstract][Full Text] [Related]
40. [Superior vena cava thrombosis in a patient on hemodialysis].
Saval N; Pou M; López Pedret J; Burrell M; Cases A
Nefrologia; 2004; 24 Suppl 3():35-8. PubMed ID: 15219066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
